Shaping the future of Japan's pharmaceutical operations

<?xml version="1.0" encoding="UTF-8"?><modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-8.xsd">
<mods version="3.8">
<titleInfo>
<title>Shaping the future of Japan's pharmaceutical operations</title>
</titleInfo>
<name type="corporate" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080442569">
<namePart>McKinsey & Company</namePart>
<nameIdentifier>MAPA20080442569</nameIdentifier>
</name>
<name type="personal" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20260007854">
<namePart>Ramirez Cárdenas, Orlando </namePart>
<nameIdentifier>MAPA20260007854</nameIdentifier>
</name>
<typeOfResource>text</typeOfResource>
<originInfo>
<place>
<placeTerm type="code" authority="marccountry">usa</placeTerm>
</place>
<issuance>monographic</issuance>
<place>
<placeTerm type="text">New York</placeTerm>
</place>
<publisher> McKinsey & Company</publisher>
<dateIssued>2026</dateIssued>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<form authority="marcform">print</form>
<extent>38 p.</extent>
</physicalDescription>
<abstract displayLabel="Summary">The report analyzes the current and future state of Japan's pharmaceutical operations in the context of global disruption, regulatory pressure, and technological change. It examines structural challenges such as pricing reforms, demographic shifts, and supply-chain vulnerabilities while highlighting opportunities from digitalization, artificial intelligence, and advanced manufacturing. The study outlines strategic priorities including zero-error quality systems, low-touch automation, modular and continuous manufacturing, and expanded use of CDMOs. Sustainability and resilience are positioned as core operational imperatives. Overall, the document provides a strategic roadmap for maintaining Japan's global leadership in pharmaceutical operations</abstract>
<tableOfContents displayLabel="Contents">Executive summary: The evolution of Japan's pharmaceutical industry -- The evolution of Japan's pharmaceutical industry: Triumphs and trials -- Trends likely to impact the operations landscape -- Themes for the future of Japanese pharmaceutical operations</tableOfContents>
<note type="statement of responsibility">by Orlando Ramirez Cárdenas...[et al.]</note>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080606633">
<topic>Industria farmacéutica</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080606091">
<topic>Estrategia empresarial</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20170006503">
<topic>Transformación digital</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080611200">
<topic>Inteligencia artificial</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080568009">
<topic>Automatización</topic>
</subject>
<subject xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080570736">
<topic>Sostenibilidad</topic>
</subject>
<subject authority="lcshac" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAPA20080650919">
<geographic>Japón</geographic>
</subject>
<classification authority="">921.8</classification>
<recordInfo>
<recordContentSource authority="marcorg">MAP</recordContentSource>
<recordCreationDate encoding="marc">260424</recordCreationDate>
<recordChangeDate encoding="iso8601">20260424142201.0</recordChangeDate>
<recordIdentifier source="MAP">MAP20260013091</recordIdentifier>
<languageOfCataloging>
<languageTerm type="code" authority="iso639-2b">spa</languageTerm>
</languageOfCataloging>
</recordInfo>
</mods>
</modsCollection>